相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Infectious recombinant Senecavirus A expressing novel reporter proteins
Minmin Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
Genetic and Chemical Engineering of Phages for Controlling Multidrug-Resistant Bacteria
Dingming Guo et al.
ANTIBIOTICS-BASEL (2021)
Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer
Valentina Foglizzo et al.
PHARMACEUTICALS (2021)
Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia
Ping Li et al.
FRONTIERS IN MICROBIOLOGY (2021)
Bacteriophage-mediated therapy of chondrosarcoma by selective delivery of the tumor necrosis factor alpha (TNFα) gene
Aitthiphon Chongchai et al.
FASEB JOURNAL (2021)
Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development
Beata Zalewska-Piatek et al.
PHARMACEUTICALS (2021)
Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
Jun-Long Liang et al.
ADVANCED MATERIALS (2021)
Protective operative techniques in radical hysterectomy in early cervical carcinoma and their influence on disease-free and overall survival: a systematic review and meta-analysis of risk groups
Johanna Kampers et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
Amy Kwan et al.
VIRUSES-BASEL (2021)
Oncolytic HSV: Underpinnings of Tumor Susceptibility
Chase Kangas et al.
VIRUSES-BASEL (2021)
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
Alexander Malogolovkin et al.
VIRUSES-BASEL (2021)
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Yaqi Zhao et al.
FRONTIERS IN MICROBIOLOGY (2021)
The role of trust in HPV vaccine uptake among racial and ethnic minorities in the United States: a narrative review
Nicole Harrington et al.
AIMS PUBLIC HEALTH (2021)
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies
Fernanda Staquicini et al.
CANCER GENE THERAPY (2020)
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrovic Fabijan et al.
NATURE MICROBIOLOGY (2020)
Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer
Xue Dong et al.
SCIENCE ADVANCES (2020)
Seneca Valley Virus 3Cpro Cleaves PABPC1 to Promote Viral Replication
Qiao Xue et al.
PATHOGENS (2020)
The Oncolytic Virus in Cancer Diagnosis and Treatment
Guo-dong Cao et al.
FRONTIERS IN ONCOLOGY (2020)
Phage display as a tool for vaccine and immunotherapy development
Krystina L. Hess et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
Seneca Valley Virus 2C and 3Cpro Induce Apoptosis via Mitochondrion-Mediated Intrinsic Pathway
Tingting Liu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Seneca Valley virus 2C and 3C inhibit type I interferon production by inducing the degradation of RIG-I
Wei Wen et al.
VIROLOGY (2019)
Recent advances in oncolytic virus-based cancer therapy
Luo-Qin Fu et al.
VIRUS RESEARCH (2019)
DNX-2401: an investigational drug for the treatment of recurrent glioblastoma
Brandon Philbrick et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Phage-based vaccines
Qing Bao et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Engineering Biomaterials to Direct Innate Immunity
Robert S. Oakes et al.
ADVANCED THERAPEUTICS (2019)
Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection
Maureen H. Fernandes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Seneca Valley Virus 3C(pro) abrogates the IRF3-and IRF7-mediated innate immune response by degrading IRF3 and IRF7
Qiao Xue et al.
VIROLOGY (2018)
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan G. Pol et al.
ONCOIMMUNOLOGY (2018)
Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus
Nadishka Jayawardena et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cervical cancer screening in rural India: Status & current concepts
Anand Narain Srivastava et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus
Linde A. Miles et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics
Jing Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity
Krystina L. Hess et al.
BIOMATERIALS (2017)
Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines
Timothy Z. Chang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2017)
Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos
Mahdi Karimi et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas
Tracey L. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Phage display as a promising approach for vaccine development
Leili Aghebati-Maleki et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Safety and efficacy of phage therapy via the intravenous route
Peter Speck et al.
FEMS MICROBIOLOGY LETTERS (2016)
M13 Bacteriophage-Based Self-Assembly Structures and Their Functional Capabilities
Jong-Sik Moon et al.
MINI-REVIEWS IN ORGANIC CHEMISTRY (2015)
Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma
Paladd Asavarut et al.
THERAPEUTIC DELIVERY (2014)
Selective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
J. T. Poirier et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus
Laura M. Hales et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus
Lalita Wadhwa et al.
CANCER RESEARCH (2007)
Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
P. Seshidhar Reddy et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Design and construction of targeted AAVP vectors for mammalian cell transduction
Amin Hajitou et al.
NATURE PROTOCOLS (2007)
A hybrid vector for ligand-directed tumor targeting and molecular imaging
A Hajitou et al.
CELL (2006)